Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Receivables (2016 - 2018)

Tenax Therapeutics' Receivables history spans 7 years, with the latest figure at $50171.0 for Q4 2017.

  • On a quarterly basis, Receivables fell 30.89% to $50171.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $50171.0, a 30.89% decrease, with the full-year FY2017 number at $50171.0, down 30.89% from a year prior.
  • Receivables hit $50171.0 in Q4 2017 for Tenax Therapeutics, up from $24649.0 in the prior quarter.
  • Over the last five years, Receivables for TENX hit a ceiling of $541463.0 in Q2 2013 and a floor of $24648.0 in Q2 2016.
  • Historically, Receivables has averaged $91111.7 across 5 years, with a median of $64662.0 in 2015.
  • Biggest five-year swings in Receivables: surged 1004.24% in 2013 and later crashed 87.79% in 2014.
  • Tracing TENX's Receivables over 5 years: stood at $123873.0 in 2013, then plummeted by 70.65% to $36358.0 in 2014, then skyrocketed by 36.0% to $49448.0 in 2015, then surged by 46.82% to $72599.0 in 2016, then tumbled by 30.89% to $50171.0 in 2017.
  • Business Quant data shows Receivables for TENX at $50171.0 in Q4 2017, $24649.0 in Q3 2017, and $24649.0 in Q2 2017.